Bacteremia due to Achromobacter xylosoxidans in neonates: Clinical features and outcome

Brazilian Journal of Infectious Diseases

Volumn 17, Issue 4, 2013, Pages 450-454

  Turel, Ozden ^a   Kavuncuoglu, Sultan ^b   Hosaf, Emine ^b   Ozbek, Sibel ^b   Aldemir, Esin ^b   Uygur, Turkan ^b   Hatipoglu, Nevin ^b   Siraneci, Rengin ^a  

^a BEZMIALEM VAKIF UNIVERSITY   (Turkey)

^b Kanuni Sultan Suleyman Education and Research Hospital   (Turkey)

Author keywords

Achromobacter xylosoxidans; Bloodstream infection; Neonate

Indexed keywords

ADRENALIN; CARBAPENEM DERIVATIVE; CEFEPIME; CEFTAZIDIME; CIPROFLOXACIN; COTRIMOXAZOLE; FLUCONAZOLE; GENTAMICIN; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; SULPERAZON; SULTAMICILLIN; VANCOMYCIN;

ABDOMINAL DISTENSION; ACHROMOBACTER XYLOSOXIDANS; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; APNEA; ARTICLE; ASEPSIS; BACTERIAL MENINGITIS; BRADYCARDIA; CLINICAL ARTICLE; CLINICAL FEATURE; COMBINATION CHEMOTHERAPY; DISEASE PREDISPOSITION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ENDOTRACHEAL INTUBATION; EPIDEMIC; FEMALE; GESTATIONAL AGE; HAND WASHING; HUMAN; IN VITRO STUDY; INFANT; INFECTION CONTROL; INTENSIVE CARE UNIT; INTRAVENOUS CATHETER; LEUKOPENIA; LOW BIRTH WEIGHT; MALE; MONOTHERAPY; NECROTIZING ENTEROCOLITIS; NEUTROPENIA; NEWBORN; NEWBORN INTENSIVE CARE; NEWBORN MORTALITY; NEWBORN SEPSIS; OUTCOME ASSESSMENT; PATIENT CODING; PNEUMONIA; PREMATURITY; RETROSPECTIVE STUDY; THROMBOCYTOPENIA; TOTAL PARENTERAL NUTRITION;

ACHROMOBACTER XYLOSOXIDANS; BLOODSTREAM INFECTION; NEONATE;

ACHROMOBACTER DENITRIFICANS; BACTEREMIA; CROSS INFECTION; DISEASE OUTBREAKS; FEMALE; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; INFANT, NEWBORN; INTENSIVE CARE UNITS, NEONATAL; MALE; RETROSPECTIVE STUDIES; TURKEY;

EID: 84880929682     PISSN: 14138670     EISSN: 16784391     Source Type: Journal    
DOI: 10.1016/j.bjid.2013.01.008     Document Type: Article

References (29)

1. Reverdy M.E., Freney J., Fleurette J., et al. Nosocomial colonization and infection by Achromobacter xylosoxidans. J Clin Microbiol 1984, 19:140-143.
2. Igra-Siegman Y., Chmel H., Cobbs C. Clinical and laboratory characteristics of Achromobacter xylosoxidans infection. J Clin Microbiol 1980, 11:141-145.
3. Yabuuchi E., Yano I., Goto S., Tanimura E., Ito T., Ohyama A. Description of Achromobacter xylosoxidans Yabuuchi and Ohyama 1971. Int J Syst Bacteriol 1974, 24:470-477.
4. Aisenberg G., Rolston K.V., Safdar A. Bacteremia caused by Achromobacter and Alcaligenes species in 46 patients with cancer (1989-2003). Cancer 2004, 101:2134-2140.
5. Dworzack D.L., Murray C.M., Hodges G.R., Barnes W.G. Community-acquired bacteremic Achromobacter xylosoxidans type III a pneumonia in a patient with idiopathic IgM deficiency. Am J Clin Pathol 1978, 70:712-717.
6. Namnyak S.S., Holmes B., Fathalla S.E. Neonatal meningitis caused by Achromobacter xylosoxidans. Clin Microbiol 1985, 22:470-471.
7. Holmes B., Snell J.J., Lapage S.P. Strains of Achromobacter xylosoxidans from clinical material. J Clin Pathol 1977, 30:595-601.
8. Vu-Thien H., Darbord J.C., Moissenet D., et al. Investigation of an outbreak of wound infections due to Alcaligenes xylosoxidans transmitted by chlorhexidine in a burns unit. Eur J Clin Microbiol Infect Dis 1998, 17:724-726.
9. Tena D., Carranza R., Barberá J.R., et al. Outbreak of long-term intravascular catheter-related bacteremia due to Achromobacter xylosoxidans subspecies xylosoxidans in a hemodialysis unit. Eur J Clin Microbiol Infect Dis 2005, 24:727-732.
10. Ahmed M.S., Nistal C., Jayan R., Kuduvalli M., Anijeet H.K. Achromobacter xylosoxidans, an emerging pathogen in catheter-related infection in dialysis population causing prosthetic valve endocarditis: a case report and review of literature. Clin Nephrol 2009, 71:350-354.
11. Melgosa M., Espinazo O., Alonso A., García Perea A., Navarro M. Dialysis-associated Alcaligenes xylosoxidans peritonitis: a pediatric case. Perit Dial Int 2004, 24:72-75.
12. Edwards M.S., Baker C.J. Sepsis in the newborn. Krugman's infectious diseases of children 2004, 545-561. Mosby, Philadelphia. 11th ed. A.A. Gershon, P.J. Hotez, S.L. Katz (Eds.).
13. Khashu M., Osiovich H., Henry D., Al Khotani A., Solimano A., Speert D.P. Persistent bacteremia and severe thrombocytopenia caused by coagulase-negative Staphylococcus in a neonatal intensive care unit. Pediatrics 2006, 117:340-348.
14. World Health Organization, Department of Communicable Disease, Surveillance and Response Prevention of hospital-acquired infections 2002, World Health Organization, Geneva, Switzerland, Publication WHO/CDS/CSR/EPH/2002.12.
15. Gales A.C., Jones R.N., Andrade S.S., Sader H.S. Antimicrobial susceptibility patterns of unusual nonfermentative Gram-negative bacilli isolated from Latin America: report from the SENTRY Antimicrobial Surveillance Program (1997-2002). Mem Inst Oswaldo Cruz 2005, 6:671-677.
16. Vu-Thien H., Moissenet D., Valcin M., Dulot C., Tournier G., Garbarg-Chenon A. Molecular epidemiology of Burkholderia cepacia, Stenotrophomonas maltophilia, and Alcaligenes xylosoxidans in a cystic fibrosis center. Eur J Clin Microbiol Infect Dis 1996, 15:876-879.
17. Aydemir Z.A., Özdemir N., Çelik N., Celkan T. Alcaligenes Xylosoxidans bacteremia in a patient with acute lymphoblastic leukemia. Mikrobiyol Bul 2009, 43:481-485.
18. Turgutalp K., Kiykim A., Ersoz G., Kaya A. Fatal catheter-related bacteremia due to Alcaligenes (Achromobacter) xylosoxidans in a hemodialysis patient. Int Urol Nephrol 2011, 44:1281-1283.
19. Öner K., Kankaya Y., Baris R., Bektas C.I., Kocer U. Calcaneal osteomyelitis due to Achromobacter xylosoxidans: a case report. J Infect Chemother 2012, (January). [Epub ahead of print].
20. Foley J.F., Gravella C.R., Englehard W.E., Chin T.D. Achromobacter septicemia-fatalities in prematures: I. Clinical and epidemiological study. Am J Dis Child 1961, 101:279-288.
21. Hearn Y.R., Gander R.M. Achromobacter xylosoxidans. An unusual neonatal pathogen. Am J Clin Pathol 1991, 96:211-214.
22. Molina-Cabrillana J., Santana-Reyes C., González-García A., Bordes-Benítez A., Horcajada I. Outbreak of Achromobacter xylosoxidans pseudobacteremia in a neonatal care unit related to contaminated chlorhexidine solution. Eur J Clin Microbiol Infect Dis 2007, 26:435-437.
23. Gómez-Cerezo J., Suárez I., Ríos J.J., et al. Achromobacter xylosoxidans bacteremia: a 10-year analysis of 54 cases. Eur J Clin Microbiol Infect Dis 2003, 22:360-363.
24. Duggan J.M., Goldstein S.J., Chenoweth C.E., Kauffman C.A., Bradley S.F. Achromobacter xylosoxidans bacteremia: report of four cases and review of the literature. Clin Infect Dis 1996, 23:569-576.
25. Shie S.S., Huang C.H., Leu H.S. Characteristics of Achromobacter xylosoxidans bacteremia in northern Taiwan. J Microbiol Immunol Infect 2005, 38:277-282.
26. Kumar A., Ray P., Kanwar M., Sethi S., Narang A. Investigation of hospital-acquired infections due to Achromobacter xylosoxidans in a tertiary care hospital in India. J Hosp Infect 2006, 62:248-250.
27. Ramos J.M., Domine M., Ponte M.C., Soriano F. Bacteremia caused by Alcaligenes (Achromobacter) xylosoxidans. Description of 3 cases and review of the literature. Enferm Infecc Microbiol Clin 1996, 14:436-440.
28. Legrand C., Anaissie E. Bacteremia due to Achromobacter xylosoxidans in patients with cancer. Clin Infect Dis 1992, 14:479-484.
29. Almuzara M., Limansky A., Ballerini V., Galanternik L., Famiglietti A., Vay C. In vitro susceptibility of Achromobacter spp. isolates: comparison of disk diffusion, Etest and agar dilution methods. Int J Antimicrob Agents 2010, 35:68-71.